Clik here to view.
Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc
Friday, December 23rd 2016 at 1:29pm UTC HAWTHORNE, N.Y.–(BUSINESS WIRE)– Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today announced the sale of U.S. rights to Keveyis®...
View ArticleClik here to view.
Synergy Pharmaceuticals Announces Positive Results in Second Phase 3 Trial of...
Thursday, December 22nd 2016 at 9:30pm UTC NEW YORK–(BUSINESS WIRE)– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from the second of two pivotal phase 3...
View ArticleClik here to view.
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From...
Friday, December 23rd 2016 at 7:05am UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced that it has completed the acquisition of the development and commercialization rights to...
View ArticleClik here to view.
Rasna Therapeutics, Inc. Closes Private Placement of $2 Million
Tuesday, December 27th 2016 at 12:16pm UTC NEW YORK–(BUSINESS WIRE)– Rasna Therapeutics, Inc. (OTCQB:RASP), a development stage biotechnology company focused on the development of cancer drugs, today...
View ArticleClik here to view.
Genexine to Present at the 35th J.P. Morgan Healthcare Conference
Wednesday, December 28th 2016 at 1:00pm UTC SEONGNAM, South Korea–(BUSINESS WIRE)– Genexine Inc. (KOSDAQ: 095700), a clinical stage biotechnology company developing innovative biologics focused on...
View ArticleClik here to view.
Acorda Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare...
Wednesday, December 28th 2016 at 12:00pm UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference...
View ArticleClik here to view.
Bristol-Myers Squibb to Take Part at the Goldman Sachs Healthcare CEOs...
Thursday, December 29th 2016 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top on...
View ArticleClik here to view.
NOXXON Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion
Wednesday, January 4th 2017 at 5:00pm UTC NOXXON Continues Transition to Clinical Oncology Company BERLIN–(BUSINESS WIRE)– class= »bwalignl »> Regulatory News: NOXXON Pharma N.V. (Alternext...
View ArticleClik here to view.
Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on...
Tuesday, January 3rd 2017 at 10:30pm UTC NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on...
View ArticleClik here to view.
Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference...
Tuesday, January 3rd 2017 at 4:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment...
View ArticleClik here to view.
Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR...
Tuesday, January 3rd 2017 at 10:00pm UTC NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on...
View ArticleClik here to view.
Momentive to Demonstrate Self-Lubricating Liquid Silicone Rubber for...
Thursday, January 5th 2017 at 3:00pm UTC WATERFORD, N.Y.–(BUSINESS WIRE)– Momentive Performance Materials Inc. (“Momentive”) announced it will be demonstrating Silopren* LSR 4655 SL liquid silicone...
View ArticleClik here to view.
Acuamark Diagnostics Announces Addition Of Haywood D. Cochrane To Its Board...
Monday, January 9th 2017 at 1:00am UTC NEW YORK–(BUSINESS WIRE)– Acuamark Diagnostics, Inc., a biotechnology company that focuses on developing accurate and cost-effective blood-based screening tests...
View ArticleClik here to view.
Bristol-Myers Squibb and GeneCentric Diagnostics Announce Exploratory...
Friday, January 6th 2017 at 11:59am UTC GeneCentric secures equity investment from Bristol-Myers Squibb Bristol-Myers Squibb to explore the use of GeneCentric’s Cancer Subtyping Platform (CSP™) NEW...
View ArticleClik here to view.
FDA Provides Positive and Encouraging Feedback for 22nd Century’s Very Low...
Thursday, January 5th 2017 at 2:15pm UTC 22nd Century Seeking Approval to Market the World’s Lowest Nicotine Tobacco Cigarettes CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE...
View ArticleClik here to view.
Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS...
Thursday, January 5th 2017 at 1:30pm UTC Marks Pfizer’s third proposed biosimilar pipeline molecule2 to report positive top-line data results within the past four months NEW YORK–(BUSINESS WIRE)–...
View ArticleClik here to view.
Medicrea to Host Investor Meetings During the 35th Annual J.P. Morgan...
Friday, January 6th 2017 at 6:30am UTC LYON, France & NEW YORK–(BUSINESS WIRE)– The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), worldwide leader pioneering the development and...
View ArticleClik here to view.
Acorda Announces 2016 AMPYRA Net Sales and 2017 Financial Guidance at J.P....
Monday, January 9th 2017 at 11:00am UTC AMPYRA 2016 Fourth Quarter Net Sales of $132 Million and 2016 Full-Year Net Sales of $493 Million (Unaudited) AMPYRA 2017 Net Sales Guidance of $535-$545...
View ArticleClik here to view.
Rgenix Announces Treatment of First Patient in Phase 1 Trial of RGX-104, its...
Friday, January 6th 2017 at 12:00pm UTC First-in-Class Cancer Therapeutic Targets the Liver X Receptor (LXR)-ApoE Pathway Identified Using Rgenix’s Discovery Platform NEW YORK–(BUSINESS WIRE)– Rgenix,...
View ArticleClik here to view.
Visioneering Technologies, Inc. Announces Mike Tilleli as New Executive...
Tuesday, January 10th 2017 at 12:00pm UTC ATLANTA–(BUSINESS WIRE)– Visioneering Technologies, Inc. (VTI), is pleased to announce that Mike Tilleli will be joined their sales team as Executive...
View Article